Citigroup’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.7K Buy
33,099
+2,899
+10% +$5.19K ﹤0.01% 4573
2025
Q4
$56.5K Buy
30,200
+10,620
+54% +$20.4K ﹤0.01% 4525
2025
Q3
$25.1K Sell
19,580
-109,338
-85% -$148K ﹤0.01% 4743
2025
Q2
$160K Sell
128,918
-153,323
-54% -$177K ﹤0.01% 4164
2025
Q1
$333K Buy
282,241
+44,550
+19% +$68.3K ﹤0.01% 3896
2024
Q4
$435K Buy
237,691
+8,591
+4% +$16.8K ﹤0.01% 3932
2024
Q3
$389K Buy
229,100
+111,697
+95% +$184K ﹤0.01% 3886
2024
Q2
$161K Buy
117,403
+66,397
+130% +$134K ﹤0.01% 3995
2024
Q1
$191K Sell
51,006
-5,307
-9% -$31.1K ﹤0.01% 4044
2023
Q4
$552K Sell
56,313
-65,552
-54% -$536K ﹤0.01% 3333
2023
Q3
$1.02M Sell
121,865
-14,480
-11% -$165K ﹤0.01% 2494
2023
Q2
$1.81M Buy
136,345
+118,613
+669% +$1.44M ﹤0.01% 2310
2023
Q1
$205K Sell
17,732
-1,837
-9% -$18.3K ﹤0.01% 3717
2022
Q4
$160K Sell
19,569
-7,186
-27% -$61.9K ﹤0.01% 3832
2022
Q3
$155K Sell
26,755
-18,154
-40% -$104K ﹤0.01% 3882
2022
Q2
$198K Buy
44,909
+2,628
+6% +$16K ﹤0.01% 3859
2022
Q1
$384K Sell
42,281
-44,885
-51% -$517K ﹤0.01% 3681
2021
Q4
$1.78M Buy
87,166
+25,455
+41% +$614K ﹤0.01% 2722
2021
Q3
$1.58M Buy
61,711
+10,906
+21% +$323K ﹤0.01% 2725
2021
Q2
$1.78M Buy
50,805
+21,095
+71% +$614K ﹤0.01% 2748
2021
Q1
$990K Sell
29,710
-36,668
-55% -$1.28M ﹤0.01% 2993
2020
Q4
$1.72M Buy
66,378
+45,071
+212% +$766K ﹤0.01% 3003
2020
Q3
$210K Sell
21,307
-33,010
-61% -$190K ﹤0.01% 4580
2020
Q2
$187K Buy
54,317
+2,378
+5% +$8.1K ﹤0.01% 5063
2020
Q1
$159K Buy
51,939
+9,044
+21% +$37K ﹤0.01% 4929
2019
Q4
$220K Sell
42,895
-131,165
-75% -$667K ﹤0.01% 5105
2019
Q3
$898K Sell
174,060
-83,532
-32% -$467K ﹤0.01% 3758
2019
Q2
$1.56M Sell
257,592
-1,990,931
-89% -$14M ﹤0.01% 3128
2019
Q1
$16.3M Buy
2,248,523
+632,464
+39% +$4.57M 0.02% 960
2018
Q4
$12M Buy
1,616,059
+1,586,116
+5,297% +$10M 0.01% 1139
2018
Q3
$162K Buy
29,943
+16,282
+119% +$69.9K ﹤0.01% 5453
2018
Q2
$48K Buy
13,661
+12,703
+1,326% +$35.2K ﹤0.01% 6324
2018
Q1
$2K Sell
958
-3,132
-77% -$8.13K ﹤0.01% 7367
2017
Q4
$11K Sell
4,090
-3,673
-47% -$12.9K ﹤0.01% 6993
2017
Q3
$41K Sell
7,763
-516
-6% -$2.22K ﹤0.01% 6096
2017
Q2
$29K Sell
8,279
-2,538
-23% -$10.2K ﹤0.01% 6104
2017
Q1
$56K Sell
10,817
-46,933
-81% -$230K ﹤0.01% 5616
2016
Q4
$219K Buy
57,750
+28,040
+94% +$204K ﹤0.01% 5204
2016
Q3
$266K Buy
29,710
+3,690
+14% +$30.8K ﹤0.01% 4443
2016
Q2
$184K Sell
26,020
-41,697
-62% -$381K ﹤0.01% 4577
2016
Q1
$575K Buy
67,717
+39,561
+141% +$389K ﹤0.01% 3975
2015
Q4
$369K Buy
28,156
+20,567
+271% +$185K ﹤0.01% 4180
2015
Q3
$28K Sell
7,589
-7,243
-49% -$35.4K ﹤0.01% 5798
2015
Q2
$86K Sell
14,832
-7,647
-34% -$44.2K ﹤0.01% 5123
2015
Q1
$131K Sell
22,479
-4,348
-16% -$30K ﹤0.01% 4831
2014
Q4
$210K Buy
26,827
+24,304
+963% +$156K ﹤0.01% 4651
2014
Q3
$13K Sell
2,523
-2,955
-54% -$15.5K ﹤0.01% 6136
2014
Q2
$33K Sell
5,478
-7,733
-59% -$38.7K ﹤0.01% 5461
2014
Q1
$71K Sell
13,211
-10,276
-44% -$65K ﹤0.01% 5260
2013
Q4
$123K Buy
23,487
+1,980
+9% +$9.09K ﹤0.01% 5079
2013
Q3
$119K Buy
21,507
+1,640
+8% +$5.69K ﹤0.01% 4589
2013
Q2
$50K Buy
+19,867
New +$49.5K ﹤0.01% 5379

Other funds holding PACB